Production (Stage)
Conduit Pharmaceuticals Inc.
CDT
$2.27
-$0.064-2.75%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -703.15% | -3,227.48% | -293.43% | 27.07% | 61.37% |
| Total Depreciation and Amortization | -- | -- | -- | -- | -- |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 298.77% | 246.61% | 867.15% | -143.09% | -252.81% |
| Change in Net Operating Assets | 44.43% | 95.35% | -158.20% | -307.42% | -601.98% |
| Cash from Operations | -43.66% | -25.35% | -180.77% | -146.63% | -135.34% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -99.17% | -98.90% | 141.38% | 1,690.91% | 327.23% |
| Cash from Investing | -104.86% | -105.93% | 112.07% | 1,645.45% | 327.23% |
| Total Debt Issued | 4,787.88% | 41.12% | -60.95% | -98.29% | -98.02% |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 7,558.94% | 2,220.53% | -82.78% | -48.34% | -73.92% |
| Repurchase of Common Stock | -- | -- | -- | 96.30% | 96.30% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -98.67% | -98.67% | -99.05% | -- | -- |
| Cash from Financing | 37.72% | -44.49% | -88.25% | 137.81% | 124.52% |
| Foreign Exchange rate Adjustments | -102.58% | -105.35% | 7,275.00% | 3,212.50% | 27,000.00% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -84.42% | -186.90% | -199.18% | 661.54% | 30,500.00% |